caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1265627996

Sharon MullisDO

Family PracticeLos Lunas, NMI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (2)

CCN 327123
Home health agency
CCN 320021
Hospital
REFERRAL NETWORK

Where Sharon Mullis's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 3 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
PRESBYTERIAN HEALTHCARE SERVICES1471,892
PRESBYTERIAN HEALTHCARE SERVICES96353
TRICORE REFERENCE LABORATORIES1180
COLEMAN, AMANDA1148
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
PRESBYTERIAN HEALTHCARE SERVICES103996
PRESBYTERIAN HEALTHCARE SERVICES67227
TRICORE REFERENCE LABORATORIES1392
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
184
Unique beneficiaries
—
Total services
277
Distinct HCPCS
3
Medicare payment
$13K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 617 Family Practice providers in NM — below median (cohort median 308).
PRESCRIBING · PART D · 2024
Total Rx claims
7,890
Beneficiaries
—
Total drug cost
$441K
Distinct drugs
144
Brand share
17.4%
Top prescribed drugs
Levothyroxine Sodium533 claims
Lisinopril388 claims
Atorvastatin Calcium381 claims
Alendronate Sodium323 claims
Losartan Potassium290 claims
QUALITY · MIPS · 2024
Final MIPS score
88.7
Quality
82.3
Cost
76.6
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.58%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.